Bone mineral accrual and low bone mass: A pediatric perspective

Reviews in Endocrine and Metabolic Disorders

Volumn 6, Issue 4, 2005, Pages 281-289

  Gelfand, Inessa M ^a,b   DiMeglio, Linda A ^a  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Bone mineral density; Evaluation; Osteoporosis; Peak bone mass; Pediatric; Treatment

Indexed keywords

ALENDRONIC ACID; ANDROGEN; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CYCLOSPORIN; ESTROGEN; GLUCOCORTICOID; GONADORELIN DERIVATIVE; GROWTH HORMONE; HEPARIN; LEVOTHYROXINE; MEDROXYPROGESTERONE ACETATE; METHOTREXATE; OSTEOPROTEGERIN; PAMIDRONIC ACID; PHOSPHORUS; RECOMBINANT PARATHYROID HORMONE; RISEDRONIC ACID; SEX HORMONE; SOMATOMEDIN C; STRONTIUM; TESTOSTERONE; THYROID HORMONE; VITAMIN D; VITAMIN D DERIVATIVE;

ANOREXIA NERVOSA; ARTIFICIAL MILK; BONE ATROPHY; BONE DENSITY; BONE DEVELOPMENT; BONE FRAGILITY; BONE MASS; BONE MINERAL; BONE REMODELING; BREAST MILK; CALCIUM ABSORPTION; CALCIUM INTAKE; CEREBRAL PALSY; CHRONIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; CORTICAL BONE; DELAYED PUBERTY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; EHLERS DANLOS SYNDROME; ENDOCRINE DISEASE; FRACTURE; GENETIC DISORDER; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEREDITY; HOMOCYSTINURIA; HORMONE SUBSTITUTION; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; HYPOGONADISM; IATROGENIC DISEASE; JUVENILE OSTEOPOROSIS; LABORATORY TEST; MARFAN SYNDROME; MEDICAL EXAMINATION; MUSCLE STRENGTH; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; OSTEOSARCOMA; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PLASTIC SURGERY; REVIEW; TURNER SYNDROME; ULTRASOUND; VITAMIN SUPPLEMENTATION; WEIGHT BEARING;

ADOLESCENT; BONE AND BONES; BONE DENSITY; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DENSITOMETRY, X-RAY; ENDOCRINE SYSTEM DISEASES; FEMALE; FRACTURES, BONE; HUMANS; INFANT, NEWBORN; MALE; MINERALS; OSTEOCHONDRODYSPLASIAS; OSTEOPOROSIS; PUBERTY;

EID: 28344454747     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11154-005-6186-y     Document Type: Review

References (62)

1. Raman L, Rajalakshmi K, Krishnamachari KA, Sastry JG. Effect of calcium supplementation to undernourished mothers during pregnancy on the bone density of the bone density of the neonates. Am J Clin Nutr 1978;31:466-169.
2. Specker BL, Johannsen N, Binkley T, Finn K. Total body bone mineral content and tibial cortical bone measures in preschool children. J Bone Miner Res 2001;16:2298-2305.
3. Specker BL, Beck A, Kalkwarf H, Ho M. Randomized trial of varying mineral intake on total body bone mineral accretion during the first year of life. Pediatrics 1997;99:E12.
4. Jones G, Riley M, Dwyer T. Breastfeeding in early life and bone mass in prepubertal children: A longitudinal study. Osteoporos Int 2000;11:146-152.
5. Greer FR, Marshall S. Bone mineral content, serum vitamin D metabolite concentrations, and ultraviolet B light exposure in infants fed human milk with and without vitamin D2 supplements. J Pediatr 1989;114:204-212.
6. Zamora SA, Rizzoli R, Belli DC, Slosman DO, Bonjour JP. Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab 1999;84:4541-1544.
7. Davies JH, Evans BA, Gregory JW. Bone mass acquisition in healthy children. Arch Dis Child 2005;90:373-378.
8. Hui SL, DiMeglio LA, Longcope C, Peacock M, McClintock R, Perkins AJ, Johnston CC, Jr. Difference in bone mass between black and white American children: Attributable to body build, sex hormone levels, or bone turnover? J Clin Endocrinol Metab 2003;88:642-649.
9. Bonjour J-P, Chevalley T, Ferrari S, Rizzoli R. Peak bone mass and its regulation. In: Glorieux F, Pettifor J, Juppner, eds. Pediatric Bone: Biology and Diseases 2003;235-248.
10. Sabatier JP, Guaydier-Souquieres G, Laroche D, Benmalek A, Fournier L, Guillon-Metz F, Delavenne J, Denis AY. Bone mineral acquisition during adolescence and early adulthood: A study in 574 healthy females 10-24 years of age. Osteoporos Int 1996;6:141-148.
11. Bailey DA, Martin AD, McKay HA, Whiting S, Mirwald R. Calcium accretion in girls and boys during puberty: A longitudinal analysis. J Bone Miner Res 2000;15:2245-2250.
12. Bradney M, Karlsson MK, Duan Y, Stuckey S, Bass S, Seeman E. Heterogeneity in the growth of the axial and appendicular skeleton in boys: Implications for the pathogenesis of bone fragility in men. J Bone Miner Res 2000;15:1871-1878.
13. Abrams SA, Griffin IJ, Hicks PD, Gunn SK. Pubertal girls only partially adapt to low dietary calcium intakes. J Bone Miner Res 2004;19:759-763.
14. Massey LK, Whiting SJ. Dietary salt, urinary calcium, and bone loss. J Bone Miner Res 1996;11:731-736.
15. Lloyd T, Beck TJ, Lin HM, Tulchinsky M, Eggli DF, Oreskovic TL, Cavanagh PR, Seeman E. Modifiable determinants of bone status in young women. Bone 2002;30:416-421.
16. Bachrach LK. Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab 2001;12:22-28.
17. Landin LA. Fracture patterns in children. Analysis of 8,682 fractures with special reference to incidence, etiology and secular changes in a Swedish urban population 1950-1979. Acta Orthop Scand Suppl 1983;202:1-109.
18. Khosla S, Melton LJ, Dekutoski MB, Achenbach SJ, Oberg AL, Riggs BL. Incidence of childhood distal forearm fractures over 30 years: A population-based study. JAMA 2003;290:1479-1485.
19. Saggese G, Baroncelli GI, Bertelloni S. Puberty and bone development. Baillieres Best Pract Res Clin Endocrinol Metab 2002;16:53-64.
20. Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A, Seeman E. The differing tempo of growth in bone size, mass, and density in girls is region-specific. J Clin Invest 1999;104:795-804.
21. Goulding A, Jones IE, Taylor RW, Manning PJ, Williams SM. More broken bones: A 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 2000;15:2011-2018.
22. Minetto M, Reimondo G, Osella G, Ventura M, Angeli A, Terzolo M. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. Osteoporos Int 2004;15:855-861.
23. Scommegna S, Greening JP, Storr HL, Davies KM, Shaw NJ, Monson JP, Grossman AB, Savage MO. Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's disease. J Endocrinol Invest 2005;28:231-235.
24. Mukherjee A, Shalet SM. Growth hormone replacement therapy (GHRT) in children and adolescents: Skeletal impact. Med Pediatr Oncol 2003;41:235-242.
25. Hsu SC, Levine MA. Primary hyperparathyroidism in children and adolescents: The Johns Hopkins Children's Center experience 1984-2001. J Bone Miner Res 2002;17(Suppl 2):N44-N50.
26. Boechat MI, Westra SJ, Van Dop C, Kaufman F, Gilsanz V, Roe TF. Decreased cortical and increased cancellous bone in two children with primary hyperparathyroidism. Metabolism 1996;45:76-81.
27. Bassett JH, Williams GR. The molecular actions of thyroid hormone in bone. Trends Endocrinol Metab 2003;14:356-364.
28. Saggese G, Bertelloni S, Baroncelli GI. Sex steroids and the acquisition of bone mass. Horm Res 1997;48(Suppl 5):65-71.
29. Soyka LA, Fairfield WP, Klibanski A. Hormonal determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab 2000;85:3951-3963.
30. van der Sluis IM, Boot AM, Krenning EP, Drop SL, de Muinck Keizer-Schrama SM. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. J Clin Endocrinol Metab 2002;87:506-512.
31. Bertelloni S, Baroncelli GI, Battini R, Perri G, Saggese G. Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res 1995;10:1488-1495.
32. Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992;326:600-604.
33. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet 2004;363:1377-1385.
34. Plotkin H. Syndromes with congenital brittle bones. BMC Pediatr 2004;4:16.
35. Grahame R, Pyeritz RE. The Marfan syndrome: Joint and skin manifestations are prevalent and correlated. Br J Rheumatol 1995;34:126-131.
36. Byers PH. Ehlers-Danlos syndrome: Recent advances and current understanding of the clinical and genetic heterogeneity. J Invest Dermatol 1994;103:47S-52S.
37. Ward LM, Glorieux FH. The spectrum of pediatric osteoporosis. In: Glorieux FH, Pettifor JM, Juppner H, eds. Pediatric Bone: Biology and Disease 2003;401-441.
38. Ross JL, Long LM, Feuillan P, Cassorla F, Cutler GB, Jr. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. J Clin Endocrinol Metab 1991;73:355-359.
39. Gravholt CH, Lauridsen AL, Brixen K, Mosekilde L, Heickendorff L, Christiansen JS. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: A cross-sectional study. J Clin Endocrinol Metab 2002;87:2798-2808.
40. Bertelloni S, Cinquanta L, Baroncelli GI, Simi P, Rossi S, Saggese G. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone. Horm Res 2000;53:72-76.
41. Mauras N, Vieira NE, Yergey AL. Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turner's syndrome: A calcium kinetic study. Metabolism 1997;46:908-913.
42. Henderson RC, Lin PP, Greene WB. Bone-mineral density in children and adolescents who have spastic cerebral palsy. J Bone Joint Surg Am 1995;77:1671-1681.
43. Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, Klibanski A. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 1999;84:4489-4496.
44. Krassas GE. Idiopathic juvenile osteoporosis. Ann NY Acad Sci 2000;900:409-412.
45. Smith R. Idiopathic juvenile osteoporosis. Am J Dis Child 1979;133:889-891.
46. Epstein DM, Dalinka MK, Kaplan FS, Aronchick JM, Marinelli DL, Kundel HL. Observer variation in the detection of osteopenia. Skeletal Radiol 1986;15:347-349.
47. Cullum ID, Ell PJ, Ryder JP. X-ray dual-photon absorptiometry: A new method for the measurement of bone density. Br J Radiol 1989;62:587-592.
48. Bachrach LK. Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition: Promise and pitfalls. J Pediatr Endocrinol 2000;13(Suppl 2):983-988.
49. Leonard MB, Feldman HI, Zemel BS, Berlin JA, Barden EM, Stallings VA. Evaluation of low density spine software for the assessment of bone mineral density in children. J Bone Miner Res 1998;13:1687-1690.
50. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva, 1994.
51. Lewiecki EM, Watts NB, McClung MR, Petak SM, Bachrach LK, Shepherd JA, Downs RW, Jr., International Society for Clinical Densitometry: Official positions of the International Society for Clinical Densitometry. J Clin Endocrinol Metab 2004;89:3651-3655.
52. Mora S, Bachrach L, Gilsanz V. Noninvasive techniques for bone mass measurements. In: Glorieux FH, Pettifor JM, Juppner H, eds. Pediatric Bone: Biology and Disease, 2003;303-324.
53. Hangartner TN, Gilsanz V. Evaluation of cortical bone by computed tomography. J Bone Miner Res 1996;11:1518-1525.
54. Baroncelli GI, Federico G, Bertelloni S, Sodini F, De Terlizzi F, Cadossi R, Saggese G. Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders. Pediatr Res 2003;54:125-136.
55. Azria M, Copp DH, Zanelli JM. 25 years of salmon calcitonin: From synthesis to therapeutic use. Calcif Tissue Int 1995;57:405-408.
56. Rodan GA. Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol 1998;38:375-388.
57. Allgrove J. Biphosphonates. Arch Dis Child 1997;76:73-75.
58. Vitte C, Fleisch H, Guenther HL. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology 1996;137:2324-2333.
59. Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. Jama 2004;292:490-195.
60. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-1441.
61. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004; 350:459-468.
62. Ray NF, Chan JK, Thamer M, Melton LJ, 3rd. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12:24-35.